Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04619316
Title Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition (ERRITI)
Acronym ERRITI
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Hospital, Essen
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Manuel M. Weber RECRUITING Essen Northrhine-Westphalia 45147 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field